AQST-203 / Libervant

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 04/10/2020

Pipeline Type

New Formulations and Indications

Phase Of Development

Phase 3

Sponsors and Collaborators

Aquestive Therapeutics

Mechanism of Action

Mechanism Description

Diazempam Buccal Soluble Film

Populations Tested In

Acute Repetitive Seizures

Special FDA Designation

Nonprofit or Government Support

N/A

Nonprofit or Government Support Description

N/A

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
AEDD XV - May 2019

Location of Clinical Trials

N/A

Join Our Newsletter

Want to get notified about new devices? Stay up to date with the latest epilepsy news and stories from the community.